For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Inovio Pharmaceuticals Inc (NASDAQ: INO) closed at $2.29 up 1.78% from its previous closing price of $2.25. In other words, the price has increased by $1.78 from its previous closing price. On the day, 0.54 million shares were traded. INO stock price reached its highest trading level at $2.305 during the session, while it also had its lowest trading level at $2.205.
Ratios:
For a deeper understanding of Inovio Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.79 and its Current Ratio is at 0.79.
Upgrades & Downgrades
In the most recent recommendation for this company, Piper Sandler on July 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $5. On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $20. Oppenheimer Upgraded its Perform to Outperform on January 25, 2024, while the target price for the stock was maintained at $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 157330736 and an Enterprise Value of 81896176. For the stock, the TTM Price-to-Sale (P/S) ratio is 874.06. Its current Enterprise Value per Revenue stands at 449.147 whereas that against EBITDA is -0.928.
Stock Price History:
The Beta on a monthly basis for INO is 1.62, which has changed by 0.2865169 over the last 52 weeks, in comparison to a change of 0.17318606 over the same period for the S&P500. Over the past 52 weeks, INO has reached a high of $2.98, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is 5.58%, while the 200-Day Moving Average is calculated to be 14.03%.
Shares Statistics:
For the past three months, INO has traded an average of 1.26M shares per day and 1881410 over the past ten days. A total of 68.70M shares are outstanding, with a floating share count of 68.42M. Insiders hold about 0.42% of the company’s shares, while institutions hold 40.93% stake in the company. Shares short for INO as of 1765756800 were 9445637 with a Short Ratio of 7.50, compared to 1763078400 on 8259257. Therefore, it implies a Short% of Shares Outstanding of 9445637 and a Short% of Float of 13.8.
Earnings Estimates
Investors are keenly observing as 4.0 analysts analyze and rate. The current performance of Inovio Pharmaceuticals Inc (INO) in the stock market.The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.33 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$2.31 and -$2.41 for the fiscal current year, implying an average EPS of -$2.35. EPS for the following year is -$1.49, with 5.0 analysts recommending between -$1.06 and -$1.95.
Revenue Estimates
A total of 6 analysts have provided revenue estimates for INO’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $65k, resulting in an average revenue estimate of $82.5k. In the same quarter a year ago, actual revenue was $217.76kBased on 6 analysts’ estimates, the company’s revenue will be $15.97M in the next fiscal year. The high estimate is $41.5M and the low estimate is $7.9M.
